What is Microdosing Tirzepatide?

A microdose is a smaller amount than the standard full dose, made to work with the body gently instead of all at once.
Unlike most GLP-1s that act on a single pathway, Tirzepatide works on two at the same time, GIP and GLP-1.³
If GLP-1 is like headphones that muffle cravings, Tirzepatide’s added GIP pathway acts like noise-cancellation, which may help turn down the food-noise hum that’s left.³
Microdosing uses lower amounts than standard doses, potentially supporting moderate weight loss for those who aren’t looking for extremes.^{4 7}
Taking smaller doses may also lower the risk of side effects, working in harmony with the body’s natural processes.⁴

The FDA has not reviewed these statements or approved this compounded product for any use, or for safety, efficacy, or quality.

MICRODOSING TIRZEPATIDE BENEFITS

Small dose. Real support.

A dose you start low and adjust gradually with your provider, personalized to your body instead of one-size-fits-all.
Microdosing may support moderate, sustainable weight loss of up to 10 pounds.⁴
Helped ease appetite and quiet the constant food noise in clinical trials.³
In a head-to-head trial at full doses, Tirzepatide supported greater weight loss than Semaglutide.⁵
A dual-action approach for stubborn weight that lifestyle changes or a single-pathway GLP-1 haven’t fully supported.⁵

*See studies cited below.

The science of Microdosing Tirzepatide

Dual-action by design: Tirzepatide is the first dual GIP and GLP-1 receptor agonist.⁴ Commonly used for type 2 diabetes and weight management, it acts on receptors in the brain, gut, and fat tissue, influencing appetite, blood sugar, and how the body handles fat.^{1 3} Recent studies have begun exploring lower doses for gentler, broader weight support.²

Emerging research in healthspan and longevity: In studies, Tirzepatide supported a favorable shift in body composition, more fat loss with preserved lean mass, while modulating inflammatory pathways and supporting cardiovascular health.⁶ Early geroscience research is now exploring GLP-1/GIP medications for their role in impacting healthspan and longevity.^{6 8}

Robert I.

Great experience so far, I’ve only been a customer for a month now but I’m already down 6 lbs. Looking forward to what I can achieve in the long run.
Kristi G.

I’m looking forward to continuing my journey towards being healthier. Morbid obesity is really hard on your joints. I can tell a big difference – a big difference – after just losing 15 lbs!
Dave P.

I’d give 6 stars if possible!! I was skeptical. But no longer. The products are of highest quality and customer service is fast, convenient and thorough. Highly recommend!
Christina A.

No hidden fees, no monthly fees. I only pay for the medication itself. I can’t stop raving about AgelessRx because every other company I looked into was the complete opposite.
Roxana T.

Wonderful, all this work and support being done by the various folks at AgelessRx is helping me toward weight loss and life longevity. Thank you all so very much!
Kevin D.

Customer service is excellent and timely response. The research and development of this company is phenomenal. Very educational.

Why AgelessRx?

Get started for less than $6/day

Personalized care guided by US-licensed clinicians

Protocols backed by our Stanford PhD-led Research Team

Every treatment is science backed, clinically vetted, and clinician-reviewed

100% online, ongoing check-ins, and free shipping

Ready to get started?
Start your free online visit now.

Starting at $159 / month billed monthly | shipped monthly

100% online medical assessment
Free shipping and ongoing support
Taken 1x weekly by subcutaneous injection
Compounded at a US-licensed pharmacy
Pause or cancel anytime

CODE MICRO140: $140 off every shipment & FREE medical evaluation

Get started

You will be automatically billed & sent refills based on your plan

You can pause or cancel at any time before your next shipment

The FDA has not approved or reviewed Microdosing Tirzepatide for safety, efficacy, quality, or for any use, including the AgelessRx compounded product. Compounded products are compounded by a licensed pharmacy.

Prescription products require an online evaluation with a licensed medical professional who will determine if a prescription is appropriate. See below for important safety information. Benefits outlined on AgelessRx.com are based on 3rd party studies. Medication is offered as a subscription service which you can cancel at any time. Actual product packaging may appear differently than shown.

FAQs

How do you microdose with GLP-1?

Microdosing GLP-1 uses the smallest measurements on your syringe. Measuring the correct dose is easy, but so is overmeasuring. Pay extra attention to the measurements on your syringe to ensure that you’re receiving the most accurate dose.

Can I transition to a regular dose if needed?

If you’re looking for a higher dose than the maximum prescribed dose, you must switch to a full-dose GLP-1 prescription. If you feel you’re not meeting your health goals on your prescribed dose, contact your provider.

See all FAQs

Important safety information and common side effects

Do not use with other GLP-1 receptor agonist medications, or any other products containing GLP-1s.

Side effects

Microdosing Tirzepatide is a low-dose Injectable GLP-1 (Tirzepatide) prescription.

Compounded GLP-1s have not been evaluated by the FDA, but side effects are expected to be similar to other GLP-1-based medications reviewed by the FDA, which have the following side effects: nausea, diarrhea, vomiting, constipation, abdominal (stomach) pain, headache, fatigue, dyspepsia (indigestion), dizziness, abdominal distension, eructation (belching), hypoglycemia (low blood sugar), flatulence (gas buildup), gastroenteritis (an intestinal infection), and gastroesophageal reflux disease (a type of digestive disorder).

Common side effects normally go away on their own within a few days or up to 2-3 weeks. Read our blog for more tips on how to manage GLP-1 side effects. If you find that any side effects persist for longer than this or get worse over time, stop taking your medication and contact your provider as soon as possible. For a full list of side effects, please review the Mayo Clinic’s Tirzepatide resources.

Other important safety information

Do not use GLP-1s if you have a personal or family history of medullary thyroid carcinoma (MTC), multiple endocrine neoplasia syndrome 2 (MEN2), or pancreatitis.

The FDA is currently evaluating whether GLP-1 medications may increase the risk of suicidal thoughts or actions. Though the FDA has found no evidence supporting this risk, users with a history of suicidal thoughts should not take GLP-1 medications.

Do not use GLP-1s if you are pregnant or breastfeeding, or planning to become pregnant or breastfeed.

Though rare, allergic reactions to GLP-1 medications are possible. If you notice any shortness of breath or swelling around your face, tongue, or throat after using GLP-1s, stop using the medication immediately and contact emergency services right away.

As with any prescription medicine, the dose prescribed is for you and you alone. Do not, under any circumstances, allow anyone else to use your prescription.

Tell your healthcare provider about all the medications you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Tell your healthcare provider if you are taking any medications to treat diabetes, including sylfonylureas or insulin.

Note: This product alone is not intended to diagnose, treat, cure, or prevent any disease. Please consult a medical professional to determine whether or not Microdosing Tirzepatide is appropriate for you.

AgelessRx’s compounded Tirzepatide has not been reviewed or approved by the FDA or analyzed by any available scientific study. However, our medical experts expect that Microdosing Tirzepatide may sustain many of the same benefits that low doses of Tirzepatide-based injectable medications have shown individually in the studies cited below.

Our idea of bedtime reading? Clinical trials.

We vet everything on PubMed so you don’t have to. Here’s what the science says.

1. This clinical study demonstrates that patients with type 2 diabetes taking Tirzepatide experience reduced hunger.	Diabetes Care, 2023
2. This recent clinical study demonstrates that lower weight loss doses of Tirzepatide are effective for weight loss.	Endocrine, 2024
3. This study highlights the superior potency of dual GLP-1 and GIP activation with Tirzepatide for type 2 diabetes management.	Diabetes Ther, 2020
4. A human trial analyzing patients on Tirzepatide injections, showing that patients on lower doses of Tirzepatide experienced fewer side effects.	Lancet Summit, 2018
5. This study highlights the superiority of Tirzepatide over Semaglutide for weight loss.	JAMA Intern Med, 2024
6. A review study of GLP-1s effects on inflammation, heart health, cognition, and multi-organ function, including Tirzepatide.	JCI, 2025
7. The results of the Novo Nordisk-sponsored SUSTAIN 7 clinical trial include weight loss outcomes for 301 participants with type 2 diabetes taking 0.5mg of Semaglutide, in addition to Metformin, showing an average of 10 pounds lost over 40 weeks.	Lancet Diabetes Endocrinol, 2018
8. This review study explores the potential healthspan and longevity benefits of GLP-1 drugs through targeting core pathways that drive biological aging.	Maturitas, 2024

Microdosing Tirzepatide